Regeneron announced that Robert Landry, executive VP, finance and CFO of Regeneron, will retire in February 2024. Christopher Fenimore, current senior VP, head of accounting and controller at Regeneron, will succeed Landry as CFO upon his retirement.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on REGN:
- Regeneron Announces Updates to Board of Directors
- Regeneron Provides Update on Planned Chief Financial Officer Transition
- Celularity enters Research Collaboration Services Agreement with Regeneron
- Regeneron treatment of myasthenia gravis granted FDA orphan status
- Biotech Alert: Searches spiking for these stocks today